These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29935886)

  • 1. Low plasma concentrations of N-methyl-d-aspartate receptor subunits as a possible biomarker for psychosis.
    Loureiro CM; Shuhama R; Fachim HA; Menezes PR; Del-Ben CM; Louzada-Junior P
    Schizophr Res; 2018 Dec; 202():55-63. PubMed ID: 29935886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder.
    Pearlman DM; Najjar S
    Schizophr Res; 2014 Aug; 157(1-3):249-58. PubMed ID: 24882425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma prevalence of anti-N-methyl-d-aspartate receptor IgG antibodies in early stages of psychosis.
    Loureiro CM; Corsi-Zuelli F; Fachim HA; Shuhama R; Chagas NMS; Menezes PR; Del-Ben CM; Louzada-Junior P
    Cien Saude Colet; 2021 Mar; 26(3):1085-1094. PubMed ID: 33729361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-NMDAR antibodies in new-onset psychosis. Positive results in an HIV-infected patient.
    Arboleya S; Clemente A; Deng S; Bedmar M; Salvador I; Herbera P; Cunill V; Vives-Bauza C; Haro JM; Canellas F; Julià MR
    Brain Behav Immun; 2016 Aug; 56():56-60. PubMed ID: 26996305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to surface dopamine-2 receptor and N-methyl-D-aspartate receptor in the first episode of acute psychosis in children.
    Pathmanandavel K; Starling J; Merheb V; Ramanathan S; Sinmaz N; Dale RC; Brilot F
    Biol Psychiatry; 2015 Mar; 77(6):537-47. PubMed ID: 25168608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia.
    Tong J; Huang J; Luo X; Chen S; Cui Y; An H; Xiu M; Tan S; Wang Z; Yuan Y; Zhang J; Yang F; Li CR; Hong LE; Tan Y
    Brain Behav Immun; 2019 Oct; 81():213-219. PubMed ID: 31201848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The validity of atypical psychosis diagnostic criteria to detect anti-NMDA receptor encephalitis with psychiatric symptoms.
    Hinotsu K; Miyaji C; Yada Y; Kawai H; Sakamoto S; Okahisa Y; Tsutsui K; Kanbayashi T; Tanaka K; Takao S; Kishi Y; Takaki M; Yamada N
    Schizophr Res; 2022 Oct; 248():292-299. PubMed ID: 36130472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum kynurenic acid is reduced in affective psychosis.
    Wurfel BE; Drevets WC; Bliss SA; McMillin JR; Suzuki H; Ford BN; Morris HM; Teague TK; Dantzer R; Savitz JB
    Transl Psychiatry; 2017 May; 7(5):e1115. PubMed ID: 28463241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to the glutamate receptor in mania.
    Dickerson F; Stallings C; Vaughan C; Origoni A; Khushalani S; Yolken R
    Bipolar Disord; 2012 Aug; 14(5):547-53. PubMed ID: 22672262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration in NMDAR-related amino acids in first episode psychosis.
    Garip B; Kayir H
    Synapse; 2019 Nov; 73(11):e22127. PubMed ID: 31403728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vivo Brain Glycine and Glutamate Concentrations in Patients With First-Episode Psychosis Measured by Echo Time-Averaged Proton Magnetic Resonance Spectroscopy at 4T.
    Kim SY; Kaufman MJ; Cohen BM; Jensen JE; Coyle JT; Du F; Öngür D
    Biol Psychiatry; 2018 Mar; 83(6):484-491. PubMed ID: 29031411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Proteomic Prediction Models for Transition to Psychotic Disorder in the Clinical High-Risk State and Psychotic Experiences in Adolescence.
    Mongan D; Föcking M; Healy C; Susai SR; Heurich M; Wynne K; Nelson B; McGorry PD; Amminger GP; Nordentoft M; Krebs MO; Riecher-Rössler A; Bressan RA; Barrantes-Vidal N; Borgwardt S; Ruhrmann S; Sachs G; Pantelis C; van der Gaag M; de Haan L; Valmaggia L; Pollak TA; Kempton MJ; Rutten BPF; Whelan R; Cannon M; Zammit S; Cagney G; Cotter DR; McGuire P;
    JAMA Psychiatry; 2021 Jan; 78(1):77-90. PubMed ID: 32857162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychiatric symptoms of a paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis: A case report].
    Le Foll J; Pelletier A
    Encephale; 2010 Apr; 36(2):166-71. PubMed ID: 20434635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia.
    Ju P; Cui D
    Acta Biochim Biophys Sin (Shanghai); 2016 Mar; 48(3):209-19. PubMed ID: 26837414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N-terminal domains of both NR1 and NR2 subunits determine allosteric Zn2+ inhibition and glycine affinity of N-methyl-D-aspartate receptors.
    Madry C; Mesic I; Betz H; Laube B
    Mol Pharmacol; 2007 Dec; 72(6):1535-44. PubMed ID: 17878266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Levels of the Cytokines B Cell-Activating Factor (BAFF) and A Proliferation-Inducing Ligand (APRIL) in Schizophrenia, Bipolar, and Major Depressive Disorder: A Cross Sectional, Multisite Study.
    Engh JA; Ueland T; Agartz I; Andreou D; Aukrust P; Boye B; Bøen E; Drange OK; Elvsåshagen T; Hope S; Høegh MC; Joa I; Johnsen E; Kroken RA; Lagerberg TV; Lekva T; Malt UF; Melle I; Morken G; Nærland T; Steen VM; Wedervang-Resell K; Weibell MA; Westlye LT; Djurovic S; Steen NE; Andreassen OA
    Schizophr Bull; 2022 Jan; 48(1):37-46. PubMed ID: 34499169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the N-Methyl-D-aspartate receptor (NMDAR)-related epitope, NR2B, in the normal human ovary: implication for the pathogenesis of anti-NMDAR encephalitis.
    Tachibana N; Kinoshita M; Saito Y; Ikeda S
    Tohoku J Exp Med; 2013 May; 230(1):13-6. PubMed ID: 23648631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoplasmic reticulum-associated degradation of the NR1 but not the NR2 subunits of the N-methyl-D-aspartate receptor induced by inhibition of the N-glycosylation in cortical neurons.
    Gascón S; García-Gallo M; Renart J; Díaz-Guerra M
    J Neurosci Res; 2007 Jun; 85(8):1713-23. PubMed ID: 17455306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-nMDA receptor encephalitis--clinical manifestations and pathophysiology].
    Iizuka T; Sakai F
    Brain Nerve; 2008 Sep; 60(9):1047-60. PubMed ID: 18807939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased platelet glycogen sysnthase kinase 3beta in first-episode psychosis.
    Joaquim HPG; Zanetti MV; Serpa MH; Van de Bilt MT; Sallet PC; Chaim TM; Busatto GF; Gattaz WF; Talib LL
    Schizophr Res; 2018 May; 195():402-405. PubMed ID: 28888361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.